McKesson Corporation provides a range of healthcare services primarily in the U.S. and internationally. Its revenue is generated from four main segments: U.S. Pharmaceutical (approximately 60%), International (20%), Medical-Surgical Solutions (15%), and Prescription Technology Solutions (5%). The U.S. Pharmaceutical segment is the largest, focusing on the distribution of various pharmaceutical products and offering services to healthcare providers and pharmacies. Factors supporting its endurance include a strong position in the pharmaceutical distribution market and ongoing demand for healthcare services, while potential limitations include regulatory changes and pricing pressures in the healthcare sector.
—
McKesson Corporation provides a range of healthcare services primarily in the U.S. and internationally. Its revenue is generated from four main segments: U.S. Pharmaceutical (approximately 60%), International (20%), Medical-Surgical Solutions (15%), and Prescription Technology Solutions (5%). The U.S. Pharmaceutical segment is the largest, focusing on the distribution of various pharmaceutical products and offering services to healthcare providers and pharmacies. Factors supporting its endurance include a strong position in the pharmaceutical distribution market and ongoing demand for healthcare services, while potential limitations include regulatory changes and pricing pressures in the healthcare sector.
—
Daily adjusted close
McKesson Corporation provides a range of healthcare services primarily in the U.S. and internationally. Its revenue is generated from four main segments: U.S. Pharmaceutical (approximately 60%), International (20%), Medical-Surgical Solutions (15%), and Prescription Technology Solutions (5%). The U.S. Pharmaceutical segment is the largest, focusing on the distribution of various pharmaceutical products and offering services to healthcare providers and pharmacies. Factors supporting its endurance include a strong position in the pharmaceutical distribution market and ongoing demand for healthcare services, while potential limitations include regulatory changes and pricing pressures in the healthcare sector.